Company logo

CNVY - Convey Health Solutions Holdings, Inc.

NYSE -> Healthcare -> Health Information Services
Fort Lauderdale, United States

CNVY price evolution
CNVY
(in millions $) 31 Mar 2022 31 Dec 2021 30 Sep 2021 30 Jun 2021
Current assets
Cash $20.87 $38.81 $40 $25.05
Short term investments
Net receivables $72.71 $62.81 $46.8 $44.56
Inventory $36.41 $14.06 $13.86 $13.19
Total current assets $140.79 $132.25 $113.55 $96.34
Long term investments
Property, plant & equipment $39.53 $20.4 $19.32 $19.44
Goodwill & intangible assets $730.55 $675.22 $679.76 $684.13
Total noncurrent assets $775.74 $697.65 $700.8 $705.91
Total investments
Total assets $916.53 $829.9 $814.36 $802.25
Current liabilities
Accounts payable $11.16 $13.87 $11.86 $8.61
Deferred revenue $9.49 $7.47 $4.66 $5.35
Short long term debt $6.89 $0.5 $0.49 $0.4
Total current liabilities $57.57 $70.4 $58.99 $54.2
Long term debt $283.55 $190.17 $190.14 $190.17
Total noncurrent liabilities $321.12 $221.76 $219.24 $218.03
Total debt $290.43 $190.67 $190.64 $190.57
Total liabilities $378.69 $292.15 $278.23 $272.23
Shareholders' equity
Retained earnings -$34.42 -$33.27 -$33.68 -$37.37
Other shareholder equity $0.02 $0.03 $0.03 $0.07
Total shareholder equity $537.85 $537.75 $536.13 $530.02
(in millions $) 31 Dec 2021 31 Dec 2020 31 Jan 2020
Current assets
Cash $38.81 $49.09 $15.97
Short term investments
Net receivables $62.81 $50.59 $49.1
Inventory $14.06 $11.09 $3.3
Total current assets $132.25 $125.83 $80.19
Long term investments
Property, plant & equipment $20.4 $20.67 $16.84
Goodwill & intangible assets $675.22 $694.05
Total noncurrent assets $697.65 $717.24 $736.59
Total investments
Total assets $829.9 $843.07 $816.78
Current liabilities
Accounts payable $13.87 $21.31 $7.37
Deferred revenue $7.47 $6.47 $7.46
Short long term debt $0.5 $2.86
Total current liabilities $70.4 $97.79 $58.79
Long term debt $190.17 $240.42 $217.25
Total noncurrent liabilities $221.76 $275.12 $288.11
Total debt $190.67 $243.28
Total liabilities $292.15 $372.92 $346.91
Shareholders' equity
Retained earnings -$33.27 -$23.29 -$16.83
Other shareholder equity $0.03 $0.08 $0.02
Total shareholder equity $537.75 $470.15
(in millions $) 31 Mar 2022 31 Dec 2021 30 Sep 2021 30 Jun 2021
Revenue
Total revenue $96.71 $97.31 $82.41 $75.25
Cost of revenue $62.71 $56.48 $45.21 $43.08
Gross Profit $33.99 $40.83 $37.2 $32.16
Operating activities
Research & development
Selling, general & administrative $23.21 $23.11 $21.3 $29.59
Total operating expenses $32.11 $33.84 $29.1 $38.97
Operating income $1.89 $6.99 $8.1 -$6.8
Income from continuing operations
EBIT $1.89 $7 $8.1 -$11.91
Income tax expense -$0.68 $4.42 $1.13 -$5.17
Interest expense $3.72 $2.17 $3.28 $6.39
Net income
Net income -$1.15 $0.41 $3.69 -$13.14
Income (for common shares) -$1.15 $0.41 $3.69 -$13.14
(in millions $) 31 Dec 2021 31 Dec 2020 31 Jan 2020
Revenue
Total revenue $337.6 $282.91 $80.42
Cost of revenue $195.32 $171.3
Gross Profit $142.28 $111.62 $33.73
Operating activities
Research & development
Selling, general & administrative $94.09 $79.95
Total operating expenses $130.47 $111.94 $46.41
Operating income $11.81 -$0.32 -$11.99
Income from continuing operations
EBIT $6.71 $10.49
Income tax expense -$0.62 -$1.9 -$0.86
Interest expense $17.31 $18.86 $5.76
Net income
Net income -$9.98 -$6.46 -$16.83
Income (for common shares) -$9.98 -$6.46
(in millions $) 31 Mar 2022 31 Dec 2021 30 Sep 2021 30 Jun 2021
Net income -$1.15 $0.41 $3.69 -$13.14
Operating activities
Depreciation $9.5 $7.81 $7.47 $7.82
Business acquisitions & disposals -$74.61
Stock-based compensation $1.26 $1.21 $1.09 $1.08
Total cash flows from operations -$15.66 $2.51 $16.25 -$8.45
Investing activities
Capital expenditures -$2.94 -$3.56 -$2.51 -$1.9
Investments
Total cash flows from investing -$77.55 -$3.56 -$2.51 -$1.9
Financing activities
Dividends paid -$74.5
Sale and purchase of stock -$0 $1.36 $146.39
Net borrowings $75.28 -$0.13 -$0.12 -$133.3
Total cash flows from financing $75.28 -$0.13 $1.24 $2.78
Effect of exchange rate -$0.01 -$0 -$0.03 -$0
Change in cash and equivalents -$17.95 -$1.19 $14.95 -$7.57
(in millions $) 31 Dec 2021 31 Dec 2020 31 Jan 2020
Net income -$9.98 -$6.46 -$16.83
Operating activities
Depreciation $30.48 $28.03
Business acquisitions & disposals -$3.76
Stock-based compensation $4.38 $6.68
Total cash flows from operations -$2.31 $31.56 -$14.39
Investing activities
Capital expenditures -$12.33 -$9.51
Investments
Total cash flows from investing -$12.33 -$13.27 -$629.85
Financing activities
Dividends paid -$74.5
Sale and purchase of stock $147.74
Net borrowings -$58.53 $21.3
Total cash flows from financing $4.41 $9.43 $665.57
Effect of exchange rate -$0.04 $0.02 $0.02
Change in cash and equivalents -$10.28 $27.74 $21.35
Fundamentals
Market cap $761.91M
Enterprise value $1.03B
Shares outstanding 73.19M
Revenue $351.67M
EBITDA $37.68M
EBIT $5.08M
Net Income -$10.20M
Revenue Q/Q 17.04%
Revenue Y/Y 16.91%
P/E ratio -74.71
EV/Sales 2.93
EV/EBITDA 27.37
EV/EBIT 203.13
P/S ratio 2.17
P/B ratio 1.42
Book/Share 7.35
Cash/Share 0.29
EPS -$0.14
ROA -1.21%
ROE -1.90%
Debt/Equity 0.54
Net debt/EBITDA 9.50
Current ratio 2.45
Quick ratio 1.81